Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

C Type Natriuretic Peptide and Polycystic Ovary Syndrome

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT04006171
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:24.682153+00:00
Published At
2021-11-05T00:00:00+00:00
Record Updated At
2021-11-05
Results Posted At
2021-11-05
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Polycystic Ovary Syndrome", "c Type Natriuretic Peptide", "Menstrual Irregularity", "Hyperandrogenism"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2021-11-05"
protocolSection.identificationModule.nctId
"NCT04006171"
protocolSection.identificationModule.officialTitle
"C Type Natriuretic Peptide and Polycystic Ovary Syndrome"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2021-11-05"

Study condition terms

  • Polycystic Ovary Syndrome (protocolSection.conditionsModule.conditions)
  • c Type Natriuretic Peptide (protocolSection.conditionsModule.conditions)
  • Menstrual Irregularity (protocolSection.conditionsModule.conditions)
  • Hyperandrogenism (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.